Albemarle Corporation shows significant potential in the specialty chemicals sector with a solid industry presence. However, fundamental ratios indicate mixed performance with room for improvement. This analysis reflects both opportunities and risks for investors.
Albemarle's fundamental scores indicate average performance, with room for improvement in cash flow and profitability metrics.
Category | Score | Visualization |
---|---|---|
Discounted Cash Flow | 1 | |
Return on Equity | 1 | |
Return on Assets | 1 | |
Debt to Equity | 2 | |
Price to Earnings | 1 | |
Price to Book | 4 |
The historical scores reflect a slight improvement in the company's overall performance over time.
Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-06-27 | 2 | 1 | 1 | 1 | 2 | 1 | 4 |
N/A | 0 | 1 | 1 | 1 | 2 | 1 | 4 |
Analyst consensus points to a median price target with moderate confidence, indicating stability but limited upside potential.
High | Low | Median | Consensus |
---|---|---|---|
85 | 68 | 68 | 73.67 |
Current analyst sentiments are neutral, with a predominant leaning towards holding the stock.
Recommendation | Count | Visualization |
---|---|---|
Strong Buy | 0 | |
Buy | 16 | |
Hold | 23 | |
Sell | 6 | |
Strong Sell | 0 |
Albemarle Corporation presents a balanced investment opportunity within the specialty chemicals industry, backed by an extensive product portfolio. The current fundamental scores suggest potential for improvement, especially in profitability metrics. Market sentiment remains neutral, guiding a cautious yet steady approach. Investors should weigh the company's innovative market presence against its financial constraints. It remains vital to continue monitoring performance and industry dynamics.